Acral Lentiginous Melanoma — Trials

Acral Lentiginous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04462406	Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial	active not recruiting	Phase 2	150	ECOG-ACRIN Cancer Research GroupNETWORK	1	Sep 15, 2026	clinicaltrials
NCT00937937	Dinaciclib in Treating Patients With Stage IV Melanoma	active not recruiting	Phase 2	72	National Cancer Institute (NCI)NIH	1	Sep 14, 2026	clinicaltrials